221 related articles for article (PubMed ID: 24982031)
1. Interaction of S100A13 with C2 domain of receptor for advanced glycation end products (RAGE).
Rani SG; Sepuru KM; Yu C
Biochim Biophys Acta; 2014 Sep; 1844(9):1718-28. PubMed ID: 24982031
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the S100A6 mutant (C3S) with the V domain of the receptor for advanced glycation end products (RAGE).
Mohan SK; Gupta AA; Yu C
Biochem Biophys Res Commun; 2013 May; 434(2):328-33. PubMed ID: 23537648
[TBL] [Abstract][Full Text] [Related]
3. S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells.
Hsieh HL; Schäfer BW; Weigle B; Heizmann CW
Biochem Biophys Res Commun; 2004 Apr; 316(3):949-59. PubMed ID: 15033494
[TBL] [Abstract][Full Text] [Related]
4. Molecular level interactions of S100A13 with amlexanox: inhibitor for formation of the multiprotein complex in the nonclassical pathway of acidic fibroblast growth factor.
Rani SG; Mohan SK; Yu C
Biochemistry; 2010 Mar; 49(11):2585-92. PubMed ID: 20178375
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into calcium-bound S100P and the V domain of the RAGE complex.
Penumutchu SR; Chou RH; Yu C
PLoS One; 2014; 9(8):e103947. PubMed ID: 25084534
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for ligand recognition and activation of RAGE.
Koch M; Chitayat S; Dattilo BM; Schiefner A; Diez J; Chazin WJ; Fritz G
Structure; 2010 Oct; 18(10):1342-52. PubMed ID: 20947022
[TBL] [Abstract][Full Text] [Related]
7. Biophysical characterization of Ca
Kim I; Lee KO; Yun YJ; Jeong JY; Kim EH; Cheong H; Ryu KS; Kim NK; Suh JY
Biochem Biophys Res Commun; 2017 Jan; 483(1):332-338. PubMed ID: 28017722
[TBL] [Abstract][Full Text] [Related]
8. Blocking the interaction between S100A9 and RAGE V domain using CHAPS molecule: A novel route to drug development against cell proliferation.
Chang CC; Khan I; Tsai KL; Li H; Yang LW; Chou RH; Yu C
Biochim Biophys Acta; 2016 Nov; 1864(11):1558-69. PubMed ID: 27524699
[TBL] [Abstract][Full Text] [Related]
9. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins.
Donato R
Curr Mol Med; 2007 Dec; 7(8):711-24. PubMed ID: 18331229
[TBL] [Abstract][Full Text] [Related]
10. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches.
Xie J; Burz DS; He W; Bronstein IB; Lednev I; Shekhtman A
J Biol Chem; 2007 Feb; 282(6):4218-31. PubMed ID: 17158877
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional insights into RAGE activation by multimeric S100B.
Ostendorp T; Leclerc E; Galichet A; Koch M; Demling N; Weigle B; Heizmann CW; Kroneck PM; Fritz G
EMBO J; 2007 Aug; 26(16):3868-78. PubMed ID: 17660747
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional solution structure of a unique S100 protein.
Sivaraja V; Kumar TK; Prudovsky I; Yu C
Biochem Biophys Res Commun; 2005 Oct; 335(4):1140-8. PubMed ID: 16122705
[TBL] [Abstract][Full Text] [Related]
13. Pentamidine blocks the interaction between mutant S100A5 and RAGE V domain and inhibits the RAGE signaling pathway.
Cho CC; Chou RH; Yu C
Biochem Biophys Res Commun; 2016 Aug; 477(2):188-94. PubMed ID: 27297108
[TBL] [Abstract][Full Text] [Related]
14. Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast.
Chiou JW; Fu B; Chou RH; Yu C
PLoS One; 2016; 11(9):e0162000. PubMed ID: 27598566
[TBL] [Abstract][Full Text] [Related]
15. The Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins.
Yatime L; Betzer C; Jensen RK; Mortensen S; Jensen PH; Andersen GR
Structure; 2016 Dec; 24(12):2043-2052. PubMed ID: 27818100
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of the variable-type domain of the receptor for advanced glycation end products: new insight into AGE-RAGE interaction.
Matsumoto S; Yoshida T; Murata H; Harada S; Fujita N; Nakamura S; Yamamoto Y; Watanabe T; Yonekura H; Yamamoto H; Ohkubo T; Kobayashi Y
Biochemistry; 2008 Nov; 47(47):12299-311. PubMed ID: 19032093
[TBL] [Abstract][Full Text] [Related]
17. The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units.
Dattilo BM; Fritz G; Leclerc E; Kooi CW; Heizmann CW; Chazin WJ
Biochemistry; 2007 Jun; 46(23):6957-70. PubMed ID: 17508727
[TBL] [Abstract][Full Text] [Related]
18. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains.
Leclerc E; Fritz G; Weibel M; Heizmann CW; Galichet A
J Biol Chem; 2007 Oct; 282(43):31317-31. PubMed ID: 17726019
[TBL] [Abstract][Full Text] [Related]
19. Tranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell Proliferation.
Huang YK; Chou RH; Yu C
J Biol Chem; 2016 Jul; 291(27):14300-14310. PubMed ID: 27226584
[TBL] [Abstract][Full Text] [Related]
20. Measuring binding of S100 proteins to RAGE by surface plasmon resonance.
Leclerc E
Methods Mol Biol; 2013; 963():201-13. PubMed ID: 23296613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
